ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Adeona Pharmaceuticals Common Stock

Adeona Pharmaceuticals Common Stock (AEN)

0.00
0.00
(0.00%)
Closed 09 January 8:00AM
0.00
0.00
( 0.00% )

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
-
Bid
-
Offer
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

AEN Latest News

Adeona Becomes Synthetic Biologics, Inc.

Adeona Becomes Synthetic Biologics, Inc. -- New Name Reflects Biotechnology Company Focus on the Emerging Field of Synthetic Biologics -- -- New NYSE Amex Ticker Symbol: SYN -- PR Newswire ANN...

Adeona CEO to Present at the Harvard Investors Group Forum

Adeona CEO to Present at the Harvard Investors Group Forum PR Newswire ANN ARBOR, Mich., Feb. 9, 2012 ANN ARBOR, Mich., Feb. 9, 2012 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN...

Adeona Appoints C. Evan Ballantyne as Chief Financial Officer

Adeona Appoints C. Evan Ballantyne as Chief Financial Officer -- Former CFO of Clinical Data, Inc. Brings Extensive Financial Background to Emerging Synthetic Biologics Company -- PR Newswire ANN...

Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biolo...

Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Company's Synthetic Biologics Strategic Focus -- Adeona Chairman, Jeff Riley, Appointed New...

Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis

Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis PR Newswire ANN ARBOR, Mich., Jan. 19, 2012 ANN ARBOR, Mich., Jan. 19, 2012...

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice Pr...

Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development -- Name Change Reflects Primary...

Company News for December 01, 2011 - Corporate Summary

•    Jos. A. Bank (NASDAQ:JOSB) posted Q3 EPS of $0.54, higher than the Zacks Consensus Estimate of $0.51 per share. Revenues increased 21% year over year to $209.6...

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator

Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator -- PNA Center for Neurological Research Clinical Study Results Presented at the 22nd International Symposium on...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary ...

Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension PR Newswire ANN ARBOR, Mich., and GERMANTOWN...

Adeona Reports Third Quarter 2011 Financial Results

Adeona Reports Third Quarter 2011 Financial Results -- Clinical Trial for Cognitive Dysfunction in Multiple Sclerosis Recruiting Patients -- PR Newswire ANN ARBOR, Mich., Nov. 14, 2011 ANN ARBOR...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AEN - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0.00
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0
AAPYKurv Yield Premium Strategy Apple AAPL ETF
US$ 26.5099
(0.00%)
0
AAPXT Rex 2X Long Apple Daily Target ETF
US$ 30.16
(0.00%)
0
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026
US$ 26.42
(0.00%)
0
AAAUGoldman Sachs Physical Gold ETF Shares
US$ 26.33
(0.00%)
0
AAAAlternative Access First Priority CLO Bond ETF
US$ 25.125
(0.00%)
0

Discussion

View Full Feed
penguincap penguincap 4 minutes ago
Hi Myst! I've just dropped you my email, thank you very much!
weedtrader420 weedtrader420 11 minutes ago
XRP LINK $10 TARGET
XRPUSD
highlandernew highlandernew 11 minutes ago
🔴🔴AMC is-now ¢0.39 cents (12.8x) NOT the MOASS LOL?!:

But anyway, after the *real* AMC post reverse split price CRASH I'll average *down* even harder?

Like... after CITADEL SLF will bring price from $20 to $2?

Then, this $2 will be the equ
AMC
BigCat BigCat 15 minutes ago
https://www.otcmarkets.com/filing/html?id=18096562&guid=QG0-kHuCxw2C9ch Shares of Beneficial Ownership: 14.1%

Pretty nice pile of insider ownership here. Hopefully they start buying up more again this year...
BXSY
manibiotech manibiotech 20 minutes ago
Even the usual apologists are running out of excuses now
NWBO
Investor2014 Investor2014 20 minutes ago
No it means assuming that the MAA survives the clock stops, which is not guaranteed.

Should that happen what is the backup plan?
AVXL
KenKong KenKong 20 minutes ago
Yes. A lot better person. Horrible Pres. 
FNMA
vvinvestorshub_free vvinvestorshub_free 26 minutes ago
Qwerty
ksquared ksquared 28 minutes ago
Thanks, Bull. Good Morning.
Been watching the CA wildfire news.
Very mixed feelings.
Anger at the idiocy running/ruining that gorgeous state.
Deep sympathy for the people who are affected.
Contempt for the celebrities who lost their homes
6of1 6of1 28 minutes ago
I hope that all experienced investors are taking advantage of this gift. This exact scenario has happened many times before
IONQ
Investor082 Investor082 31 minutes ago
Agreed. Its always blame game and excuses, but never about the execution by the company and what it does for the shareholders.

For instance, why haven't they applied in the EU? Why didn’t they submit reimbursement evidence in the UK immediately following the MAA submission?
NWBO
capgain capgain 34 minutes ago
So sad to see the devastation there Star, stay safe.
ksquared ksquared 37 minutes ago
Cal-i-for-ni-a is run by D.E.I. idiots...
https://nypost.com/wp-content/uploads/sites/2/2025/01/JANUARY09.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
edbi46 edbi46 44 minutes ago
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!


Lets see how high our beloved BIEL gets TRUMP
BMI MCF WBA
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 53 minutes ago
Anavex is just procrastinating hoping that in a year or so a non-rejection by EMA will make it more likely that FDA will say yes.

So "non-rejection" is the new term for "approval" for those trying to hold the stock down? 🤣

Carvillesque.
AVXL
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 57 minutes ago
is there EVER a final guidance?

Why would the bureaucrats want to lock themselves in like that. Limits their arbitrary power (and lunches from lobbyists)
AVXL
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 1 hour ago
Exactly. We've seen this for years.

Stocks are like wave in the ocean, move in peaks and troughs. The relevant question is whether the tide is rising or dropping longer term, and it is definitely rising going into JPM conference.
JPM
olekbolek olekbolek 1 hour ago
as i can see you guys are now focused on the feuerstein topic, because all company topics were discussed in an endless loop. investorhub needs fresh nwbo-content for more clicks - so, go out and find something new nwbo-content while nwbo itsself (as always) is silent for what reason ever
NWBO

Your Recent History

Delayed Upgrade Clock